Burden of dementia following stroke subtypes: a study integrating the GBD database and Mendelian randomization

Meng Jin1, Jingjing Liu2, Ziyi Bao2

  • 1Department of Neurology, Zhoushan Hospital, Zhejiang University, School of Medicine, Zhoushan 316000, Zhejiang Province, China.

Insights

Stroke, both ischemic and hemorrhagic, contributes to 1.31% of global dementia cases. Identifying modifiable risk factors and cerebrospinal fluid mediators offers new avenues for dementia prevention and treatment.

Area of Science:

  • Neurology
  • Epidemiology
  • Genetics

Background:

  • Established causal link between stroke and dementia.
  • Increasing global dementia prevalence necessitates understanding contributing factors.
  • Lack of effective dementia interventions highlights the need for etiological research.

Purpose of the Study:

  • Estimate global and regional proportions of dementia following ischemic and hemorrhagic strokes.
  • Analyze trends in stroke-related dementia.
  • Identify risk factors and mediators for vascular dementia using Mendelian randomization.

Main Methods:

  • Literature review and Bayesian regression to estimate dementia risk post-stroke.
  • Global Burden of Disease (GBD) data utilized for calculating population attributable fractions (PAF) and disease burden.
  • Two-sample and two-step Mendelian randomization (MR) applied to GWAS data for risk factor and mediator identification.

Main Results:

  • Hemorrhagic stroke showed a higher relative risk (RR: 3.02) of dementia than ischemic stroke (RR: 2.07).
  • Ischemic stroke accounted for a higher PAF due to its prevalence, with both stroke types explaining 1.31% of global dementia.
  • Significant spatial and temporal heterogeneity in dementia burden post-stroke was observed; MR identified causal risk factors and a CSF metabolite mediator (X-11261).

Conclusions:

  • Ischemic and hemorrhagic strokes collectively account for 1.31% of global dementia prevalence.
  • Quantifying stroke's contribution enhances understanding of dementia etiology.
  • Identified modifiable risk factors and CSF mediators provide targets for dementia prevention and treatment strategies.
Abstract

Related Concept Videos

Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
165
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.1K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666